Geode Capital Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.4K | Sell |
305,964
-5,534
| -2% | -$1.67K | ﹤0.01% | 4079 |
|
|
2025
Q1 | $88.8K | Sell |
311,498
-9,346
| -3% | -$2.66K | ﹤0.01% | 4068 |
|
|
2024
Q4 | $188K | Hold |
320,844
| – | – | ﹤0.01% | 3926 |
|
|
2024
Q3 | $143K | Buy |
320,844
+13,659
| +4% | +$6.09K | ﹤0.01% | 4005 |
|
|
2024
Q2 | $814K | Buy |
307,185
+6,948
| +2% | +$18.4K | ﹤0.01% | 3388 |
|
|
2024
Q1 | $823K | Buy |
300,237
+16,910
| +6% | +$46.3K | ﹤0.01% | 3436 |
|
|
2023
Q4 | $689K | Hold |
283,327
| – | – | ﹤0.01% | 3492 |
|
|
2023
Q3 | $572K | Sell |
283,327
-10,205
| -3% | -$20.6K | ﹤0.01% | 3548 |
|
|
2023
Q2 | $866K | Sell |
293,532
-338,816
| -54% | -$1,000K | ﹤0.01% | 3407 |
|
|
2023
Q1 | $1.58M | Buy |
632,348
+29,795
| +5% | +$74.5K | ﹤0.01% | 3127 |
|
|
2022
Q4 | $1.91M | Buy |
602,553
+9,849
| +2% | +$31.2K | ﹤0.01% | 3065 |
|
|
2022
Q3 | $1.76M | Buy |
592,704
+17,763
| +3% | +$52.7K | ﹤0.01% | 3125 |
|
|
2022
Q2 | $1.75M | Buy |
574,941
+11,904
| +2% | +$36.3K | ﹤0.01% | 3159 |
|
|
2022
Q1 | $7.6M | Buy |
563,037
+3,537
| +0.6% | +$47.7K | ﹤0.01% | 2534 |
|
|
2021
Q4 | $7.29M | Buy |
559,500
+173,752
| +45% | +$2.26M | ﹤0.01% | 2660 |
|
|
2021
Q3 | $3.62M | Sell |
385,748
-24,542
| -6% | -$230K | ﹤0.01% | 3102 |
|
|
2021
Q2 | $4.2M | Buy |
410,290
+161,729
| +65% | +$1.66M | ﹤0.01% | 3007 |
|
|
2021
Q1 | $4.57M | Buy |
248,561
+28,708
| +13% | +$528K | ﹤0.01% | 2833 |
|
|
2020
Q4 | $7.53M | Buy |
+219,853
| New | +$7.53M | ﹤0.01% | 2346 |
|